Placebo Tablet: BID

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc., Dr. Bryan Strelow

Conditions

Diabetic Macular EdemaPhenylketonuria

Phase 1

Kamuvudine-9 (K9) in Diabetic Macular Edema

RecruitingNCT07458061

Dr. Bryan StrelowDiabetic Macular Edema

Start: 2026-02-01End: 2026-08-01Target: 10Updated: 2026-03-10

Phase 3

A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)

RecruitingNCT06971731

Otsuka Pharmaceutical Development & Commercialization, Inc.Phenylketonuria

Start: 2025-10-20End: 2028-04-01Target: 120Updated: 2026-04-02